- Home
- AUGO vs VCEL Comparison
AUGO vs VCEL Comparison
Compare AUGO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUGO
- VCEL
- Stock Information
- Founded
- AUGO 1946
- VCEL 1989
- Country
- AUGO United States
- VCEL United States
- Employees
- AUGO N/A
- VCEL N/A
- Industry
- AUGO
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AUGO
- VCEL Health Care
- Exchange
- AUGO Nasdaq
- VCEL Nasdaq
- Market Cap
- AUGO 1.8B
- VCEL 2.1B
- IPO Year
- AUGO N/A
- VCEL 1997
- Fundamental
- Price
- AUGO $25.24
- VCEL $40.12
- Analyst Decision
- AUGO
- VCEL Strong Buy
- Analyst Count
- AUGO 0
- VCEL 8
- Target Price
- AUGO N/A
- VCEL $62.00
- AVG Volume (30 Days)
- AUGO 565.6K
- VCEL 558.9K
- Earning Date
- AUGO 08-05-2025
- VCEL 07-31-2025
- Dividend Yield
- AUGO 3.57%
- VCEL N/A
- EPS Growth
- AUGO N/A
- VCEL 521.85
- EPS
- AUGO N/A
- VCEL 0.05
- Revenue
- AUGO $623,889,000.00
- VCEL $238,541,000.00
- Revenue This Year
- AUGO N/A
- VCEL $23.03
- Revenue Next Year
- AUGO N/A
- VCEL $24.52
- P/E Ratio
- AUGO N/A
- VCEL $772.69
- Revenue Growth
- AUGO 38.03
- VCEL 14.80
- 52 Week Low
- AUGO $23.50
- VCEL $34.87
- 52 Week High
- AUGO $25.57
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- AUGO N/A
- VCEL 51.37
- Support Level
- AUGO N/A
- VCEL $34.87
- Resistance Level
- AUGO N/A
- VCEL $41.00
- Average True Range (ATR)
- AUGO 0.00
- VCEL 1.77
- MACD
- AUGO 0.00
- VCEL 0.21
- Stochastic Oscillator
- AUGO 0.00
- VCEL 67.83
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.